Additionally, CCL3 is significantly overexpressed in NEC mice, exacerbating inflammatory bowel injury by modulating macrophage chemotaxis, which highlights CCL3 as a potential therapeutic target in NEC [19]. This evidence concerns the gene CCL3 and necrotizing enterocolitis.